MARKETING AGREEMENT

                               MARKETING AGREEMENT


THIS MARKETING AGREEMENT  ("Agreement") is entered into effective as of the (21)
day of February 2006, by and between Trillennium Medical Imaging,  Inc. a wholly
owned subsidiary of Wellstar  International,  Inc., a Nevada  Corporation having
its  principal  place  of  business  in  Ohio,  ("Licensor")  and  Marty  Ellis,
President, Allevia Medical, ("Rep.").

                                   WITNESSETH:

WHEREAS,  Licensor holds the exclusive rights to certain advanced,  FDA approved
thermal  imaging  cameras,  related  software and equipment,  (the  "Trillennium
System")  and has the  ability  to provide  related  training  services,  all as
further specified herein (the "Trillennium Services"); and

WHEREAS,  the Trillennium System  incorporates  certain patents,  patent pending
applications,   proprietary   inventions,   know-how,   and  other  Confidential
Information (the "Licensed Technology"); and

WHEREAS,  Rep. has existing or seeks to develop  relationships with certain pain
clinics,  imaging  clinics,  wound care  facilities,  hospitals,  nursing homes,
nursing  home  management  companies,   ambulatory  care  facilities  and  other
healthcare providers in which Rep. believes it will be beneficial to utilize the
Trillennium System; and

WHEREAS,  Licensor  desires  to  appoint  Rep.  as its  non-exclusive  Marketing
Representative   for  the  purpose  of  assisting   Licensor  in  expanding  its
Trillennium Services client base, it is

NOW, THEREFORE,  AGREED, in consideration of the mutual promises set forth below
and other good and valuable consideration,  the receipt and sufficiency of which
all parties hereto hereby acknowledge, as follows:

1.   Recitals.   The  above   recitals  are  true  and  correct  and  are  fully
     incorporated into the body of this Agreement as if fully rewritten herein.

2.   Definitions.

     a.   "Commencement  Date"  means the date upon which Rep.  places its first
          order  for  Thermal  Imaging  Systems  in  accord  with the  terms and
          conditions hereof.

     b.   "Confidential  Information" means and collectively includes all secret
          and  confidential  Technical  Information,   as  hereinafter  defined,
          including all specifications,  data, drawings, explicated know-how and
          experience,   trade   secrets,   software,   databases,    proprietary
          information  and any documents  owned by Licensor which pertain to the
          Thermal Imaging  Cameras and/or is used in the  Trillennium  Services,
          including  but not limited to the Licensed  Technology,  to the extent
          that such  information:  (i) was not known to the recipient;  (ii) was
          not  disclosed  in  published  literature;  (iii)  was  not  generally
          available in the  industry;  and/or (iv) has not been  divulged to the
          recipient by a third party.

     c.   "Licensed  Rights"  means and includes the right to obtain and use the
          Trillennium  System in Rep.'s  present or future pain  and/or  imaging
          clinics or such other  entities  with  which Rep.  shall  successfully
          arrange a License Agreement for the use of the Trillennium System.

     d.   "Technical  Information"  means  unpublished  research and development
          information,  market and business  information,  patented  inventions,
          patent   applications,    know-how,   trade   secrets,   manufacturing
          information, computer programs and computer design programs, technical
          data and  management  or  supervisory  know-how in the  possession  of
          Licensor as of the  Commencement  Date, or as  subsequently  acquired,
          developed,  produced or otherwise  available to the Licensor following
          the Commencement Date and throughout the term of this Agreement.
<PAGE>
3.   Enhancements.

     a.   Licensor shall  promptly  notify Rep. of any and all  enhancements  or
          improvements  (hereinafter  all  included in the term  "Enhancements")
          relating to the Trillennium Services, including but not limited to the
          Trillennium   System  and/or   Licensed  Rights  which  are  hereafter
          developed by the Licensor, and Rep. shall have the right to market all
          such   Enhancements,   subject  to  such   reasonable  fees  for  such
          Enhancements   as  Licensor   may,  in  its  sole   discretion,   deem
          appropriate,  as  though  originally  included  in the grant of rights
          hereunder.

     b.   Rep.  agrees  that it will  notify  Licensor  of any  Enhancements  it
          develops or  discovers.  Rep.  hereby  grants to Licensor the right to
          unencumbered  use and to secure  patent  rights  in such  Enhancements
          developed by Rep. as part of the  consideration  received by Rep. from
          Licensor for the right to market the Trillennium  Services as provided
          for herein.

4.   Repair and Maintenance.  Rep. agrees to immediately  notify Licensor of any
     defects in any equipment or other materials  provided by Licensor  pursuant
     to  the  terms  of  this   Agreement.   Any  repairs  and/or   replacements
     necessitated  by the negligence  and/or  intentional  acts of Rep.,  Rep.'s
     employees,  agents,  contractors  or other invitees shall be made at Rep.'s
     sole expense. 5. Nondisclosure of Confidential Information.

     a.   All  Confidential  Information  and/or  materials  made  available  by
          Licensor to Rep.  hereunder  shall remain so until such time, if ever,
          as the material is no longer confidential through no action,  inaction
          or fault of Rep. and shall be kept and maintained as confidential  and
          shall  not be  disclosed  by  Rep.  to any  third  party  unless  such
          information and/or materials are published or enter the public domain.

     b.   For the  purposes of  compliance  with the privacy  provisions  of the
          Health Insurance  Portability and  Accountability Act of 1996 (HIPAA),
          Rep.  and  Licensor's  relationship  with each  other are as  "Covered
          Entities." As used hereunder,  the terms "Covered Entity",  "Protected
          Health  Information",  "use" and "disclosure"  shall have the meanings
          ascribed to them in 42 CFR Section 164.501.

     c.   Rep. and the Licensor each agree to conduct their respective  business
          in accordance  with all  applicable  laws and  regulations,  including
          HIPAA and the regulations promulgated thereunder.

6.   Marketing Rights and Obligations.

     a.   Licensor appoints Rep. as its non-exclusive  Marketing  Representative
          for the purpose of facilitating  Trillennium System  installations and
          License   arrangements   (each  an   "Arrangement"   and  collectively
          "Arrangements")  between  Licensor  and  such  third  parties  (each a
          "Prospect" and  collectively  "Prospects")  that (a) are introduced to
          Licensor by Rep. and/or its agents and/or  representatives  during the
          Term (defined below) hereof and (b) with whom Licensor does not have a
          pre-existing  relationship  (whether  business or personal)  with such
          Prospect  or its  representatives  (as  evidenced  by the  records  of
          Licensor)  (a   "Pre-existing   Relationship").   If  a   Pre-existing
          Relationship  is in place  Licensor will notify Rep.  within three (3)
          business  days of the date on which a Prospect's  name is presented if
          Licensor has a Pre-existing  Relationship with such Prospect, and will
          promptly  thereafter  provide Rep. with evidence from Licensor records
          of such Pre-existing Relationship.  Rep. accepts such appointment, and
          agrees to use its best efforts to facilitate such Arrangements.

                                       2
<PAGE>
     b.   Rep. agrees that during the Term hereof,  any extension thereof or for
          so long as Licensor  shall be paying  Commissions to Rep. for services
          rendered hereunder, Rep. shall neither market, represent nor recommend
          any  product  or  service  competing,  directly  or  indirectly,  with
          Licensor's Trillennium System or any component thereof.

     c.   With regard to Rep.'s marketing activities, Rep. agrees that:

          i.   Licensor  may,  at  Licensor's  sole  option,  be involved in all
               planning and marketing presentations;

          ii.  Rep.'s right to  participate  in any seminars,  trade show,  etc,
               with Licensor  shall be at Licensor's  sole  discretion,  on such
               terms and conditions as Licensor,  shall, in it's sole discretion
               determine, on a case by case basis;

          iii. All pricing, use fee and other financial  determinations shall be
               determined solely by Licensor, in Licensor's sole discretion, and
               Rep.  shall  not  make  any  representations  regarding  the same
               without Licensor's express written consent;

          iv.  Rep.  understands  and agrees  that in the event Rep.  introduces
               another  individual or group which Licensor agrees to engage as a
               marketing  representative,  then and in that  event,  Rep.'s sole
               compensation  arising  therefrom  or from any business or fees of
               any kind or  nature  generated  from or  through  such  marketing
               representative  shall be in the form of a credit of the number of
               timely  paid not  repeat  imaging  sessions  generated  from such